Aims We have previously reported that Centchroman (CC), an oral contraceptive drug,
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …

Metastatic spread during carcinogenesis worsens disease prognosis and accelerates the
cancer progression. Therefore, newer therapeutic options with higher specificity toward …

Aims Angiogenesis is a recognized hallmark of cancer which promotes cancer cell
progression and metastasis. Inhibition of angiogenesis to attenuate cancer growth is …

Chemotherapy is an effective treatment for invasive breast cancer. Paradoxically, many
recently published findings showed that the first-line chemotherapeutic agent paclitaxel …

Breast cancer is one of the most frequently diagnosed cancer in woman. Triple-negative
breast cancer (TNBC) is most aggressive form of breast cancer. There is a growing interest …

Background Breast cancer is one of the most prevalent gynecologic malignancies
worldwide. Despite the high sensitivity in response to chemotherapy, drug resistance …

Cardamonin (CD), an active chalconoid, has shown potent anticancer effects in preclinical
studies; however, the effect and underlying mechanism of CD for the treatment of triple …

Baicalein (BAI) is an acknowledged flavonoids compound, which is regarded as a useful
therapeutic pharmaceutical for numerous cancers. However, its involvement in melanoma is …

Background: Centella asiatica (CA) has been used to address cancer for centuries in
traditional Chinese medicine (TCM). Previous studies demonstrated its anti-angiogenesis …

Abstract Ethnopharmacological relevance Zhuidu Formula (ZDF) is composed of triptolide,
cinobufagin and paclitaxel, which are the active ingredients of Tripterygium wilfordii Hook. F …